The federal law that makes possession of marijuana a crime has its origins in legislation that was passed in an atmosphere of hysteria during the 1930s and that was firmly rooted in prejudices against Mexican immigrants and African-Americans, who were associated with marijuana use at the time. This racially freighted history lives on in current federal policy, which is so driven by myth and propaganda that it is almost impervious to reason.
It took 13 years for the United States to come to its senses and end Prohibition, 13 years in which people kept drinking, otherwise law-abiding citizens became criminals and crime syndicates arose and flourished. It has been more than 40 years since Congress passed the current ban on marijuana, inflicting great harm on society just to prohibit a substance far less dangerous than alcohol. The federal government should repeal the ban on marijuana. (See also: Why the New York Times editorial series calling for marijuana legalization is such a big deal and Evolving on Marijuana)
When the poster child for marijuana legalization is released from a U.S. prison later this week, he'll be re-entering a world where many of his ideas have taken root and in some places have sprouted right up. Marc Emery, Canada’s self-styled “Prince of Pot,” concludes a five-year sentence and will emerge into a lucrative marijuana landscape, where two U.S. states are now issuing recreational pot licences, medical growers are reaping profits and investors aren’t hedging on potential opportunities.
The Community Anti-Drug Coalition of America (CADCA), one of the largest anti-legalization organizations in the US has a curious sponsor: Purdue Pharma, the manufacturer of Oxy-Contin, the highly addictive painkiller that has been linked to thousands of overdose deaths nationwide. A familiar confederation of anti-pot interests have a financial stake in the status quo, including law enforcement agencies, pharmaceutical firms, and nonprofits funded by federal drug-prevention grants.
As the world marks the United Nations' International Day Against Drug Abuse and Illicit Trafficking, millions of drug addicts in Russia have nowhere to go for treatment, and specialists are in despair over the lack of progress in the country's rehabilitation system. The Federal Drug Control Service, or FSKN, recently announced plans to create a system of communes to treat drug addicts, but drug counselors dismiss such statements as empty promises.
Today, khat joined the range of prohibited substances that fall under the UK Misuse of Drugs Act 1971. Those who distribute this Class C drug can now face 14 years imprisonment – the same maximum sentence that applies to individuals who cause death by dangerous driving, and four years more than the maximum penalty for sexual assault. So what exactly is khat, and why has it attracted such harsh legislation? (See also: Khat: Update - Ban to be implemented on the 24th of June)
Police have been officially advised to use their discretion in deciding how to enforce the ban on qat, a mild herbal stimulant, that has been widely used in Britain's Somali, Yemeni and Ethiopian communities. Official guidelines from the Association of Chief Police Officers tells constables that in applying a "three strikes" enforcement policy they should take into account that qat has "historically not been a controlled drug and was part of the culture of certain communities linked to the Horn of Africa." (See also: Stimulant khat banned as illegal class C drug in UK)
Martha Fernback, 15, died from taking 91% pure ecstasy. The response of her mother, Anne-Marie Cockburn was unusual. She refused to blame her daughter, her friends, or the dealer or the manufacturer. Cockburn, a single mother, focused on a greater target: the government. "It quickly became obvious that prohibition had had its chance but failed," she said. "Martha is a sacrificial lamb under prohibition. The question is: how many more Marthas have to die before we change our approach? It's not acceptable to allow the risks to remain."
A recent neuroscience study from Harvard Medical School claims to have discovered brain differences between people who smoke marijuana and people who do not. Such well-intentioned and seemingly objective science is actually a new chapter in a politicized and bigoted history of drug science in the United States. Different-looking brains tell us literally nothing about who these people are, what their lives are like, why they do or do not use marijuana, or what effects marijuana has had on them.
Dr Hans-Christian Raabe, who was removed from the Advisory Council on the Misuse of Drugs after one month, this week wrote two rather provocative articles on the Conservative Woman website. Raabe’s main argument is that a better, “alternative approach to the drug problem” would be to create a “drug-free society”. Punitive, zero-tolerance, abstinence-based approaches have been the dominant drug policy model in most parts of the world for over half a century now – and they haven’t worked. They've caused a great deal of harm and haven’t really stopped people taking drugs.
The Expert Group on the Economics of Drug Policy was convened to produce the most thorough independent economic analysis of the current international drug control strateg ever conducted. It aims to use this analysis to design a successor strategy to the failed global war on drugs. In so doing it will provide the academic underpinnings for a new international paradigm that promotes human security, public health and sustainable development.
Kofi Annan Secretary General of the United Nations, Fernando Henrique Cardoso
05 November 2013
Each year, hundreds of thousands of people around the world die from preventable drug-related disease and violence. Millions of users are arrested and thrown in jail. Globally, communities are blighted by drug-related crime. Citizens see huge amounts of their taxes spent on harsh policies that are not working. But despite this clear evidence of failure, there is a damaging reluctance worldwide to consider a fresh approach. The Global Commission on Drug Policy is determined to help break this century-old taboo. See IDPC Press Release.
The UK's drug laws are preventing scientists from carrying out vital research to unlock our understanding of the brain and find new treatments for conditions such as depression and Parkinson's disease, according to Professor David Nutt, a leading neuroscientist and former government drug adviser. "Things are actually getting worse," said Nutt, referring to the restrictions placed on research.
The global “war on drugs” has been such a failure that illegal substances are now cheaper and purer than at any period over the past two decades, warns a new report by the Vancouver-based International Centre for Science in Drug Policy. Data from seven international government-funded drug surveillance systems show that drug use should be considered a public health rather than a criminal justice issue.
For four decades, libertarians, civil rights activists and drug treatment experts have stood outside of the political mainstream in arguing that the war on drugs was sending too many people to prison, wasting too much money, wrenching apart too many families -- and all for little or no public benefit. They were always in the minority. But a sign of a new reality emerged: for the first time in four decades of polling, the Pew Research Center found that more than half of Americans support legalizing marijuana.
"Since declaring a war on drugs 40 years ago, the United States has spent more than a trillion dollars, arrested more than 45 million people, and racked up the highest incarceration rate in the world. Yet it remains laughably easy to obtain illegal drugs. So why do we continue down this same path? Why do we talk about the drug war as if it's a success? It's a charade." (See: The house I live in)
German officials take a decidedly cool stance toward drug policy reform. No top politician with a major German party is about to call for a new drug policy or even the legalization of marijuana. Drugs are not a winning issue, because it's too easy to get burned. Germany lacks the political pressure to change. There were 986 drug-related deaths in Germany in 2011, the smallest number since 1988. Drug use is declining in all age groups. So why change anything?